Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
Lijun Ning(Shanghai Institute of Hematology), Jie Hong(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University), Muni Hu(Shanghai Jiao Tong University), Jinmei Ding(Shanghai Jiao Tong University), Zhe Cui(Shanghai Jiao Tong University), Haoyan Chen(Shanghai Jiao Tong University), Han Sun(Xuzhou Medical College), Yanru Ma(Shanghai Jiao Tong University), Xiaoqiang Zhu(Shanghai Institute of Hematology), Chaoqin Shen(Sun Yat-sen University), Yuqing Yan(Shanghai Jiao Tong University), Zhenhua Wang(Shanghai Jiao Tong University), Youwei Zhang(Shanghai University), Xiaowen Huang(Shanghai Jiao Tong University), Tianying Tong(Shanghai Jiao Tong University), Ying Zhao(Shanghai Jiao Tong University), Jing‐Yuan Fang(Shanghai Institute of Hematology), Yue Zhang(First Hospital of Lanzhou University), Yilu Zhou(Shanghai Jiao Tong University)
Cited by 231
Related Papers
Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
Roles of Chk1 in cell biology and cancer therapy
|International Journal of Cancer|2013|456
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|427